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Secondary erythrocytosis in cyanotic congenital heart disease (CCHD) is a compensatory response to chronic hypoxia which
should bemanaged with caution. CCHDpatients, who have compensated erythrocytosis but do notmanifest significant neurologic
symptoms, may experience secondary life-threatening complications such as stroke in case of inappropriate phlebotomy.This study
reports a young man with CCHD who developed frequently repeated transient neurologic deficits with various presentations after
one session of phlebotomy.The symptoms resolved a few days after the hematocrit (Hct) level returned to the prephlebotomy level.
1. Introduction
Secondary erythrocytosis is a physiological response to tissue
hypoxia inwhich there are an increased number of circulating
red blood cells, an improved oxygen carrying capacity, and an
enhanced blood viscosity.This adaptation results in sufficient
tissue oxygenation at a higher blood viscosity and Hct; how-
ever this equilibrium may be impaired if excessive erythro-
cytosis impairs oxygen delivery by increasing blood viscosity
and eventually inverses the beneficial effects of erythrocytosis
[1]. Cerebrovascular event has been previously considered
as one of the most serious complications of secondary
erythrocytosis in CCHD, although a large study in adult
patients with CCHD showed no increased risk of stroke [2].
Patients with secondary erythrocytosis related to CCHD
can be divided into two groups as follows: first group with
stable “compensated” erythrocytosis, adequate iron stores,
and absent or mild hyperviscosity symptoms and second
group with “decompensated” erythrocytosis, iron deficiency
states, and recurrent hyperviscosity symptoms [3].
For patients with compensated secondary erythrocytosis,
phlebotomy did not indicate any usefulness when they
exhibit mild,moderate, or no neurologic symptoms related to
cerebral hyperviscosity. Repeated phlebotomy was associated
with iron stores depletion, microcytosis, blood hyperviscos-
ity, and impaired oxygen delivery [4].
In this paper, we report a 35-year-old man with com-
plex CCHD, who showed unusual presentation of recurrent
various transient neurologic deficits after first therapeutic
phlebotomy.
2. Case
A 35-year-old man is presented here as a known case of
complex CCHD including dextrocardia, ventricular septal
defect, transposition of the great arteries, atrial septal defect,
pulmonary stenosis, with a history of previous admission for
cardiac evaluation, and catheterization for diagnosis of heart
anatomy and RV pressure 25 years ago. However, the patient
has not shown any symptoms and no surgical intervention
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has been done on the patient. He had been feeling well until
2 days before admission when he reported some neurological
symptoms like dizziness, tingling, and fatigue. He was visited
by an internist who advised him to undergo a phlebotomy,
250 cc with normal saline replacement, for three continuous
days due to his high Hct level (Hct: 64.5). After the first ses-
sion, Hct and hemoglobulin (Hb) oxygen saturation were 58
and 76%, respectively. At the second session of phlebotomy,
immediately after several unsuccessful painful intravenous
angiocut catheter insertions, the patient developed tongue
and right body tingling and paresthesia, later progressed to
dysarthria and stiffness and tightness in right extremities
which were resolved in about 20 seconds. During recovery,
the same symptoms occurred in the left upper limb which
were all resolved completely in about 30 seconds. Emergency
brain CT has not showed cerebral hemorrhage or infarction
and brain magnetic resonance imaging (MRI) and diffu-
sion weighted MR has not revealed any more information.
Transthoracic echocardiography did not also show obvious
thrombus. The patient was admitted in stroke unit and
hydration, medication with aspirin 80mg, and infusion of
heparin with rate of 1000 unit per hour started. Although the
patient was on antiplatelet and anticoagulant, his symptoms
frequently recurred in various forms alternating in both sides:
right and left hemiparesis, stiffness, loss of dexterity, chorea
and dystonic movement, facial and tongue tingling, and
paresthesia. During symptomatic period, neurologic exam-
ination revealed transient Babinski signs at several times.
The patient’s complaints continued for several days and since
day 4 after presentation, frequency and severity of symptoms
decreased. Brain and neck MR angiography, cervical MRI,
Transcranial Doppler (TCD) sonography and monitoring,
and electroencphalography were normal. Other blood count
parameters (white blood cell: 7000 cells/mcL, mean corpus-
cular volume: 84 fL, and platelet count: 155000 cells/mcL),
serum iron (88𝜇g/dL), ferritin (110 ng/mL), and homocys-
teine (13 𝜇mol/L) were in normal range. After discharge of
the patient from hospital, frequency and severity of the
neurologic attacks gradually decreased coinciding with an
increase in Hb and Hct. Terminally, his complaint resolved
at an Hct level (62.7%) and an Hb O
2
saturation (85%) near
to the amount before admission. Onemonth later, the patient
only occasionally complained from a limb tingling similar to
the symptom before phlebotomy.
3. Discussion
Our patient manifested repeated transient neurologic deficits
after the first session of phlebotomy and his symptoms were
compatible with the involvement of various cerebral areas,
probably originating from an ischemic process.
Polycythemic cyanotic patients experience two different
symptoms of hyperviscosity symptoms and thrombotic event
[1]. The former symptom, hyperviscosity, can sometimes be
misinterpreted as thrombotic event and lead to inappropriate
phlebotomies [3]. Hyperviscosity is generally associated with
impaired tissue perfusion and tissue oxygen delivery which
causes symptoms such as headache, visual disturbance, loss of
concentration, paresthesia, muscle weakness, and fatigue [3].
The more serious presentation of polycythemia is throm-
botic event inclusive of cerebrovascular accident (CVA) and
transient ischemic attacks (TIA)which are usuallymanifested
[3] as symptoms or signs of hemiparesis and/or hemisensory
defects, cortical blindness, aphasia, dysarthria, dysphagia
ataxia, or drop attacks, distinguishing thrombotic event from
hyperviscosity [5].
Our patient had both types of symptoms: firstly he
presented limb tingling and dizziness that was related to
hyperviscosity, but after a single therapeutic phlebotomy, he
developed unusual various transient symptoms that seemed
to have resulted from ischemia. Several mechanisms might
be involved in cerebral ischemia in patients with CCHD
like hyperviscosity, iron deficiency anemia, thrombosis, or
associated vascular risk factor [2, 3].
Despite a correlation between Hct level and vascular
occlusive in polycythemia vera (PV), the association between
hyperviscosity and vascular thrombosis is not yet reported
in adult patients with CCHD and secondary erythrocytosis
[3]. Although PV is associated with vascular accident such
as stroke [5], Perloff et al. did not report an increased
incidence of cerebral infarction in adult patients who suffer
from CCHD and secondary erythrocytosis [4]. Ammash and
Warnes reported an increased risk of CVAs in adult patients
with CCHD which related to hypertension, atrial fibrillation,
repeated phlebotomies, and iron deficiency, but they have
not mentioned any correlation between Hg or Hct level and
stroke [2].
Therapeutic guidelines in PV recommend maintaining
Hct level lower than 45 through phlebotomy. However, it is
not proved that phlebotomy is associated with a lower risk of
thrombosis, because iron deficiency resulting from frequent
phlebotomy may even cause a higher incidence of vascular
occlusion [1].
Patients with CCHD who do not have hyperviscosity
symptoms are not advised to have phlebotomy unless patient
is symptomatic atHct level above 65 and is not dehydrated [1].
Dehydration and iron deficiencymay precipitate or aggravate
symptomatic hyperviscosity and thrombotic event and have
to be managed before phlebotomy in patients with CCHD
with Hct level of >65% [3].
If venesection is performed without volume replacement
in patient suffering from dehydration, the consequences of
the acute fall in systemic blood flow and oxygen delivery
can impair cardiovascular and cerebral perfusion [1]. Iron
deficiency anemia is associated with microcytic erythrocytes
that are rigid and difficult to pass through microcirculation,
ultimately increasing the risk of hyperviscosity symptoms
and CVAs in patients with secondary erythrocytosis [3].
Our patient did not have iron deficiency because one
session of phlebotomy is not enough for iron depletion to
occur and serum iron and ferritinwere also in a normal range.
Suspicious of probable dehydration, the patient was treated
with sufficient intravenous solution, which did not resolve the
patient’s symptoms.
Dinia et al. reported a 29-year-old woman with a cor-
rected CCHD suffering from advancing pulmonary hyper-
tension and secondary erythrocytosis (Hct: 63%). After two
sessions of therapeutic phlebotomy, the patient experienced
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three instances of TIA that disappeared immediately after the
infusion of heparin.The Hct value after first phlebotomy was
57.5%. Bilateral TCD monitoring showed several microem-
bolic signals (MES) on middle cerebral arteries of both sides
which disappeared after anticoagulant therapy. The authors
believe that the clinical events may be due to hyperviscosity
and microembolization of aggregated red blood cells [6].
However, in our patient, treatment with heparin infusion
did not resolve neurologic episodes which were frequently
repeated every few minutes. TCD sonography and monitor-
ing have not shown any significant arterial stenosis andMES,
respectively. MES considered silent cerebral emboli that are
usually detected during TCD monitoring of the intracranial
arteries [7]. There seems to be another mechanism involved
in pathogenesis of neurologic episodes in our case.
Despite improvement of tissue oxygen delivery and cere-
bral blood flow following phlebotomy, blood oxygen carrying
capacity decreases in secondary erythrocytosis [8].
Our case had an Hct level about 64.5% and an Hb O
2
saturation around 85%, which decreased after phlebotomy
to 58% and 76%, respectively. His neurologic deficit attacks
appeared after a decrease in Hct levels andHb oxygen satura-
tion. Gradually, there was a cut in the frequency of these
attacks and their eventual disappearance coincided with an
increase in Hb O
2
saturation and Hct level to the prephle-
botomy status. It is possible that phlebotomy has caused
a reduced arterial oxygen saturation and finally might be
manifested as neurologic deficits.
In conclusion, our case manifested unusual neurologic
deficits after one session of inappropriate phlebotomy. The
deficits resolved only after Hct level reached the prephle-
botomy level. It is important to note that lack of knowl-
edge about the abovementioned unusual presentations as a
result of injudicious phlebotomy and accompanying probable
mechanisms may result in inappropriate and occasionally
life-threatening treatments such as anticoagulation therapy.
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